The delay in commercialising GM mustard after regulatory clearance in 2017 may have cost the country up to ₹30,900 crore in lost output, higher imports
CATALYST – Collaboration for Agricultural Transformation through Advanced Learning, Science & Technology, a new initiative aimed at strengthening collaboration between research and industry to deliver
Mumbai: Doctors in India are increasingly testing “dose optimisation” to make high-cost treatments affordable while cutting side-effects, and Tata Memorial Hospital’s latest findings underline how
As India enters 2026, its medical devices sector stands at an inflection point. The convergence of targeted manufacturing incentives, regulatory consolidation, and sustained healthcare demand
Drug resistance is outpacing industrywide efforts, says Netherlandsbased Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven
Amid the ongoing conflict involving Israel, the United States and Iran, efforts are underway to resolve disruptions in India’s agricultural exports to West Asia. However,
Escalating geopolitical tensions in the Middle East and disruptions in the strategically vital Strait of Hormuz are raising concerns across the global dairy industry, with
In a research greenhouse in eastern China’s Zhejiang province, a batch of ordinary-looking tomatoes carry a scent more commonly associated with movie theaters than farmers’
Dr Reddy’s Laboratories is strategically shifting focus towards biosimilars and innovation. The company is increasing investment in biosimilars, anticipating significant growth within five years. Generics
Mumbai: A new study from the Tata Memorial Centre has highlighted that many modern cancer medicines, especially immunotherapy, are far too expensive for most people
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump